---
$id: https://graph.org.ai/products/commodity/51392206
$type: Product
source: UNSPSC
code: "51392206"
title: "Metizoline"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metizoline

**UNSPSC Code**: 51392206
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an imidazole with the molecular formula C13H14N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z27L8N105U, chemically known as 1h-imidazole, 4,5-dihydro-2-((2-methylbenzo(b)thien-3-yl)methyl)- but generally known as metizoline, which bears US NIH Compound Identifier 28688. European Medicines Agency schedules Metizoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08898MIG. World Health Organization schedules metizoline in its Anatomical Therapeutic Chemical (ATC) Classification. METIZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metizoline under HS 29349990 and SITC 51579. As of Q4 2014, METIZOLINE remains the US FDA Preferred Term for this commodity. Metizoline bears US NLM identifiers UMLS ID C0604284 and NCI Concept Code C99577. SMILES: S1C(C(CC2=NCCN2)C2C1CCCC2)C.

